Mask Network price pumps then dumps as whales sell
Mask Network token surged to its highest point since December last year and then suffered a harsh reversal.
Mask Network (MASK), a privacy-focused token, rose to $3.6766, and then erased those gains and moved towards $2.
On-chain data shows that the whale transaction count jumped. Santiment data shows that these transactions jumped to 26, its highest point since May 28.
A deeper dive reveals that these whales are selling the Mask token. The supply of held by whales dropped to 28.26 million on Friday, the lowest level on record.
More data shows that the 180-day and 365-day mean dollar invested age or MDIA has been in a strong downward trend. The 180-day figure dropped to 29.6, down from 50 in May, while the 365-day figure plunged to 38 from 70.
The MDIA figure looks at the average age of all coins weighted by their purchase price in US dollar terms. A falling figure is usually a bearish sign for a cryptocurrency.
The other bearish sign for the Mask Network is its negative funding rate in the past few days. This happens when more traders are shorting an asset and are thus paying bullish ones a small fee.
Mask Network price technical analysis
The daily chart shows that the MASK price surged to a high of $3.7020 and then suffered a harsh reversal to $2.3300. It dropped below the key support at $2.50, the highest swing on April 1.
The Relative Strength Index tilted downwards, moving from a high of 80 to 54. Therefore, the token will likely continue falling as sellers attempt to move below $2 and the 50-day and 200-day moving averages. Sustained selling may see it drop to $0.9475, the lowest point in April.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Revenue and profit guidance exceeds expectations across the board! Without Jensen Huang, is Nvidia (NVDA.US) still maintaining its AI narrative as usual?
Nvidia raised its performance guidance, while also denying the possibility of Jensen Huang's return.
Microsoft (MSFT.US) Ignite Conference Releases Six Dedicated AI Models: Challenging OpenAI and Anthropic with Lower Costs
Microsoft is making significant progress in building its own cutting-edge general-purpose AI models and has launched six dedicated AI models at the Ignite conference.

A key return for the $10.6 billion acquisition! GlaxoSmithKline (GSK.US) lung cancer drug Nelkarmi approved for market launch, targeting a multi-billion dollar market
The lung cancer drug neladalkib from GlaxoSmithKline has been approved for market by the US Food and Drug Administration (FDA), further validating the strategic value of the British pharmaceutical company's previous acquisition of the biotechnology company Nuvalent.
Hyperliquid revenue diversification rises as $4B daily volume shifts from crypto to stocks

